Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,807.55 INR | +0.53% |
|
+0.98% | -24.49% |
17/05 | Hester Biosciences Limited, Q4 2025 Earnings Call, May 09, 2025 | |
09/05 | Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025 | CI |
Company Valuation: Hester Biosciences Limited
Data adjusted to current consolidation scope
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 13,146 | 7,869 | 16,306 | 23,099 | 12,934 | 11,818 |
Change | - | -40.14% | 107.21% | 41.66% | -44% | -8.63% |
Enterprise Value (EV) 1 | 13,627 | 8,900 | 17,190 | 25,128 | 15,528 | 14,109 |
Change | - | -34.69% | 93.14% | 46.18% | -38.21% | -9.14% |
P/E ratio | 31.6x | 27x | 47.4x | 58.7x | 48.6x | 62.6x |
PBR | 7.41x | 3.91x | 7.14x | 8.88x | 4.62x | 4.05x |
PEG | - | -0.9x | 2.6x | 4.1x | -1.5x | -2.2x |
Capitalization / Revenue | 7.14x | 4.19x | 7.49x | 9.37x | 4.65x | 3.8x |
EV / Revenue | 7.4x | 4.74x | 7.9x | 10.2x | 5.58x | 4.53x |
EV / EBITDA | 18.4x | 14.7x | 23.9x | 35.2x | 24.9x | 23.5x |
EV / EBIT | 21.8x | 18.8x | 29.1x | 45.7x | 36.9x | 32.7x |
EV / FCF | 340x | -18.6x | 1,007x | -32.9x | -30.6x | 128x |
FCF Yield | 0.29% | -5.38% | 0.1% | -3.04% | -3.27% | 0.78% |
Dividend per Share 2 | 11 | 6.6 | 10 | 10 | 8 | 6 |
Rate of return | 0.71% | 0.71% | 0.52% | 0.37% | 0.53% | 0.43% |
EPS 2 | 48.86 | 34.29 | 40.47 | 46.22 | 31.3 | 22.2 |
Distribution rate | 22.5% | 19.2% | 24.7% | 21.6% | 25.6% | 27% |
Net sales 1 | 1,842 | 1,878 | 2,177 | 2,466 | 2,782 | 3,112 |
EBITDA 1 | 742.6 | 604 | 720.3 | 712.9 | 624.2 | 600 |
EBIT 1 | 625.6 | 472.3 | 591.2 | 550.4 | 420.3 | 431.3 |
Net income 1 | 415.7 | 291.7 | 344.3 | 393.2 | 266.3 | 188.9 |
Net Debt 1 | 481.8 | 1,031 | 884.3 | 2,030 | 2,593 | 2,291 |
Reference price 2 | 1,545.30 | 925.05 | 1,916.75 | 2,715.30 | 1,520.45 | 1,389.25 |
Nbr of stocks (in thousands) | 8,507 | 8,507 | 8,507 | 8,507 | 8,507 | 8,507 |
Announcement Date | 05/07/19 | 04/08/20 | 23/07/21 | 29/07/22 | 23/08/23 | 26/07/24 |
1INR in Million2INR
Estimates
P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
---|---|---|---|---|---|---|
- | - | - | - | 18Cr | ||
25.95x | 7.75x | 17.62x | 1.29% | 6.9TCr | ||
-1064.29x | 2.41x | 12.69x | -.--% | 740Cr | ||
18.63x | 1.65x | 7.89x | 1.9% | 366.64Cr | ||
18.1x | 1.99x | 10.01x | 0.47% | 333.97Cr | ||
46.66x | 4.98x | 17.74x | -.--% | 230.43Cr | ||
28.26x | 1.44x | 9.67x | 1.56% | 124.84Cr | ||
20.37x | 2.64x | 11.41x | 2.27% | 124.69Cr | ||
15.42x | 1.24x | 6.29x | 1.23% | 107.6Cr | ||
30.12x | - | - | 1.46% | 107.26Cr | ||
Average | -95.64x | 3.01x | 11.67x | 1.13% | 905.23Cr | |
Weighted average by Cap. | -63.53x | 6.53x | 16.20x | 1.16% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- HESTERBIO Stock
- Valuation Hester Biosciences Limited
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition